Home » Author Archive

**GlucoTrack (NASDAQ: GCTK) Approves Increase in Authorized Shares**WASHINGTON, D.C. 20549 – GlucoTrack, Inc. (NASDAQ: GCTK) reported on January 3, 2025, that they held a Special Meeting of its stockholders in which they approved an amendment to the

Posted by Ed Jones on Jan 8th, 2025

** This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read GlucoTrack’s 8K filing here. GlucoTrack Company Profile (Get Free Report) GlucoTrack,... More of this article »

Blaine Davis Sells 4,028 Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Stock

Posted by Ed Jones on Jan 8th, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Get Free Report) CFO Blaine Davis sold 4,028 shares of the stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $16.83, for a total transaction... More of this article »

Minerva Neurosciences (NASDAQ:NERV) Now Covered by StockNews.com

Posted by Ed Jones on Jan 8th, 2025

StockNews.com initiated coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) in a research note released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately,... More of this article »

Willamette Valley Vineyards (NASDAQ:WVVI) Earns Hold Rating from Analysts at StockNews.com

Posted by Ed Jones on Jan 8th, 2025

StockNews.com assumed coverage on shares of Willamette Valley Vineyards (NASDAQ:WVVI – Free Report) in a research report released on Sunday. The brokerage issued a hold rating on the stock. Willamette Valley Vineyards Trading... More of this article »

Ferrexpo (LON:FXPO) Trading Down 7.9% – Time to Sell?

Posted by Ed Jones on Jan 7th, 2025

Ferrexpo plc (LON:FXPO – Get Free Report) was down 7.9% during mid-day trading on Tuesday . The company traded as low as GBX 98.40 ($1.23) and last traded at GBX 99.10 ($1.24). Approximately 2,716,206 shares changed hands during... More of this article »